Pompe Registry – A Decade of Making a Difference

Category: Archive
November 12, 2015

Youtube video by Genzyme Corp., published April 08, 2015

In 2014, the Pompe Registry recognized and celebrated an important milestone: the 10-year anniversary of the Registry. Started in 2004 and sponsored by Genzyme, a Sanofi company, the Pompe Registry was established as a global, voluntary, observational database to collect and report on the natural history and outcomes of patients with Pompe disease through routine clinical practice, regardless of patient treatment status. This video highlights the importance of the Registry through interviews with physicians in the field and patients with Pompe disease. (Source: https://www.youtube.com/watch?v=hnjzV7dkbhs)

The video includes statements of Pompe medical professionals and Pompe patients participating in the registry:

  • Dr. Mark Roberts, UK
  • Dr. Sharon Krueger, First Pompe Registry Patient
  • Dr. Priya Kishnani, USA
  • Dr. Mary-Alice Abbott, USA
  • Dr. Edward Cupler, Saudi Arabia
  • Dr. David Stockton, USA
  • Prof. Antonio Toscano, Italy
  • Prof. Juan Llerena, Brazil
  • Abby Phelps, Pompe Registry Patient
  • Prof. Ans van der Ploeg, The Netherlands
  • Dr. Barry Byrne, USA
  • Dr. Yin-Hsiu Chien, Taiwan
  • Dr. Kenneth Berger, USA
  • Prof. Wolfgang Müller-Felber, Germany
  • Dr. Paula Clemens, USA
  • Dr. Virginia Kimonis, USA
  • Dr. Laura Case, USA

The Pompe Registry is an important program that Genzyme sponsors and administers. A disease registry contains medical information on patients with a specific condition, in a database that can be analyzed and used by physicians treating patients with the same condition. Registries have proven to be especially valuable in rare diseases like Pompe disease. Information submitted to the Pompe Registry will be maintained as confidential in accordance with applicable national privacy regulations and other state and local laws related to medical information. (Source: https://pompe.com/)

More information


Disclaimer: The IPA does not endorse any of the products, medications, treatments or information reported herein. Articles on the IPA web pages are intended for informational purposes, only. We strongly advise that you discuss all medications, treatments, and/or products with your physician.


Back to news articles